Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease

NICE technology appraisal guidance [TA111] Published date:

Important information about this guidance

Important information about this guidance

This guidance has been updated and replaced by NICE technology appraisal 217.

Get involved